Human Genome Sciences, Inc. (HGSI) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts HGSI Hot Sheet
Join SI Premium – FREE
Human Genome Sciences, Inc. (NASDAQ: HGSI) reported Q2 EPS of ($0.42), $0.01 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $24.9 million versus the consensus estimate of $29.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
